DPHAY - Dechra Pharmaceuticals PLC GAAP EPS of $0.37 revenue of $332.4M February, 22 2022 08:21 AM Dechra Pharms Plc Adr Dechra Pharmaceuticals PLC (OTC:DPHAY): 2H GAAP EPS of $0.37. Revenue of $332.4M (+10.9% Y/Y). For further details see: Dechra Pharmaceuticals PLC GAAP EPS of $0.37, revenue of $332.4M